
Company valuation, historical trends, and peer comparisons.
According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 116.30M. This represents a change of -8.58% compared to the average of 127.21M of the last 4 quarters.
The mean historical Enterprise Value of Recce Pharmaceuticals Ltd over the last ten years is 80.47M. The current 116.30M Enterprise Value has changed 44.52% with respect to the historical average. Over the past ten years (40 quarters), RECEF's Enterprise Value was at its highest in in the December 2025 quarter at 198.83M. The Enterprise Value was at its lowest in in the December 2012 quarter at 0.
Average
80.47M
Median
92.64M
Minimum
14.78M
Maximum
143.47M
Discovering the peaks and valleys of Recce Pharmaceuticals Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.22%
Maximum Annual Enterprise Value = 143.47M
Minimum Annual Increase = -32.74%
Minimum Annual Enterprise Value = 14.78M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 124.85M | 80.84% |
| 2025 | 69.04M | -32.74% |
| 2024 | 102.66M | -4.44% |
| 2023 | 107.43M | -25.12% |
| 2022 | 143.47M | 15.91% |
| 2021 | 123.78M | 49.80% |
| 2020 | 82.63M | 300.22% |
| 2019 | 20.65M | 33.89% |
| 2018 | 15.42M | 4.36% |
| 2017 | 14.78M | 41.11% |
The current Enterprise Value of Recce Pharmaceuticals Ltd (RECEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
98.85M
5-year avg
109.49M
10-year avg
80.47M
Recce Pharmaceuticals Ltd’s Enterprise Value is greater than Island Pharmaceuticals Limited (67.07M), greater than Biotron Limited (1.73M), greater than Botanix Pharmaceuticals Limited (-3957777.00), greater than Immuron Limited (1.30M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 67.07M | $79.95M | |
| 1.73M | $3.29M | |
| -3957777.00 | $17.93M | |
| 1.30M | $10.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Recce Pharmaceuticals Ltd's Enterprise Value?
What is the highest Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?
What is the 3-year average Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?
What is the 5-year average Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?
How does the current Enterprise Value for Recce Pharmaceuticals Ltd (RECEF) compare to its historical average?